Phase I Study of Sintilimab in Healthy Chinese Male Subjects
Clinical trial NCT05337267 · COMPLETED
Trial details
- NCT number
- NCT05337267
- Sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-13
- Primary completion
- 2023-05-24
- Enrollment
- 117
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.